Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Unknown 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Endocrine 1

Conditions

Breast Neoplasms 54Lung Neoplasms 29Colorectal Neoplasms 24Prostatic Neoplasms 23Colonic Neoplasms 16Rectal Neoplasms 14Carcinoma, Non-Small-Cell Lung 14Neoplasms 13Uterine Cervical Neoplasms 12Lymphoma 11Urinary Bladder Neoplasms 8Leukemia 8Endometrial Neoplasms 8Depression 8Pancreatic Neoplasms 7Ovarian Neoplasms 7Leukemia, Myeloid, Acute 7Breast Carcinoma In Situ 7Precursor Cell Lymphoblastic Leukemia-Lymphoma 6Pain 6Multiple Myeloma 6Melanoma 6Hematologic Neoplasms 6Carcinoma, Ovarian Epithelial 6Anxiety Disorders 6Obesity 5Leukemia, Lymphocytic, Chronic, B-Cell 5Hematopoietic and Lymphatic System Neoplasm 5Fatigue 5Burkitt Lymphoma 5

Interventions

lanreotide 1Temozolomide 1Surveys and Questionnaires 1Solutions 1Radiosurgery 1Microarray Analysis 1Injections 1Early Intervention, Educational 1Diet, Mediterranean 1Diet, Ketogenic 1DNA Methylation 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Growth Hormone-Secreting Pituitary Adenoma × Early Intervention, Educational × Clear all
NCT01775332 2015-07-31

Interdisciplinary Pituitary Disorders Centre of Excellence: Assessment of Patient Education Tools

Unity Health Toronto

Phase NA Unknown
60 enrolled
Endocrine

Gigantism, Pituitary Neoplasms, Prolactinoma, Growth Hormone-Secreting Pituitary Adenoma, ACTH-Secreting Pituitary Adenoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡